Global Advisory Board
As the leader in global life science supply chain management, Marken continues to be the forerunner for promoting industry trends and innovation as well as establishing international best practices. This has led to the formation of a strategic and technical board of global advisors.
This group has been hand-picked to provide Marken clients with evolving industry knowledge and perspectives for every aspect of the end to end Pharmaceutical Supply Chain. The internationally recognized experience of the advisory board positions Marken to provide consulting and leadership to its clients globally and will represent Marken as opinion leaders.
Advisory Board Members:
Rafik H. Bishara, PhD is the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association PDA) formerly Director, Quality Knowledge Management and Technical Support with Eli Lilly & Co. for 35 years.
Dr. Bishara received his Ph.D. from Purdue University, Indiana, USA, adding to his B.S. Pharmacy & Pharmaceutical Chemistry and an M.S. Phytochemistry from Butler University, Indianapolis, USA
Dr. Bishara has authored numerous articles, and technically advised several organizations on Good Cold Chain and Temperature – Controlled Management.
Laurent Foetisch is Founder and Managing Director of Supply Chain Operations SA, formerly Vice President of Global Supply Chain for Merck Serono and Serono for over 20 years.
Schooling: Villamont, Lausanne
College: Business School, Lausanne
Training: 6 Sigma, Business in China, Coaching for Peak Performance, IMD Lausanne
Alan Horgan is an independent consultant working with Whiteacres Associates LLC and formerly Group Vice President, Late Stage Development MDS Pharma Services and Corporate Senior Vice President & Global President of Clinical Development for Covance.
Mr. Horgan began his career at ER Squibb and Sons moving swiftly up through the ranks in Sales and Marketing. A year after the merger with Bristol – Myers he moved to Boots Pharmaceuticals and as Managing Director of the UK and Irish Pharmaceutical Companies, oversaw the launch of several new products in the cardiovascular and non steroidal inflammatory markets. He led the team that was to eventually license in Pantoprozole from German Pharmaceutical maker Byk Gulden.
Hedley Rees is Managing Consultant, Biotech PharmaFlow expert in Lean Thinking and Production Systems. Hedley is a strong advocate of the regulatory modernization frameworks of FDA’s 21st Century Modernization and ICH Q8 – Q11.
“Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics”, J Wiley & Sons, Hoboken, NJ 2011
“Virtual Pharma, But Not Virtual Responsibility”, Pharmaceutical Formulation & Quality, February/March 2009
“ICH Q9 and Beyond”. European Biopharmaceutical Review, Autumn 2009
“Delivering 21st Century Modernization Through Effective Supply Chain Management” European Biopharmaceutical Review, Autumn 2010
“A New Model for Product Development” Chemistry Today (peer reviewed), Jan/Feb 2011
To find out more about how Marken’s advisory board can help your organization, email firstname.lastname@example.org or fill out our short contact form: